Privia Health Group (NASDAQ:PRVA) Announces Earnings Results, Beats Estimates By $0.23 EPS

Privia Health Group (NASDAQ:PRVA) issued its quarterly earnings data on Thursday. The company reported $0.29 EPS for the quarter, topping the consensus estimate of $0.06 by $0.23, Briefing.com reports. The business had revenue of $580.42 million during the quarter, compared to analyst estimates of $494.98 million. Privia Health Group had a net margin of 0.89% and a return on equity of 2.52%. Privia Health Group’s quarterly revenue was up 32.5% compared to the same quarter last year. During the same period last year, the business posted $0.20 earnings per share. Privia Health Group updated its FY 2025 guidance to EPS.

Privia Health Group Stock Down 2.3%

Shares of NASDAQ PRVA traded down $0.55 during midday trading on Friday, hitting $23.43. The stock had a trading volume of 1,382,680 shares, compared to its average volume of 791,019. The company has a market cap of $2.88 billion, a P/E ratio of 180.24, a PEG ratio of 3.27 and a beta of 0.83. The business’s 50 day moving average is $24.15 and its 200-day moving average is $22.77. Privia Health Group has a 52 week low of $18.77 and a 52 week high of $26.51.

Analysts Set New Price Targets

Several research analysts have recently issued reports on the company. Evercore ISI increased their target price on Privia Health Group from $28.00 to $30.00 and gave the stock an “outperform” rating in a research report on Friday. Zacks Research upgraded Privia Health Group from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 19th. Piper Sandler dropped their target price on shares of Privia Health Group from $36.00 to $35.00 and set an “overweight” rating on the stock in a report on Monday, August 11th. Citizens Jmp upped their target price on shares of Privia Health Group from $30.00 to $31.00 and gave the stock a “market outperform” rating in a research report on Friday. Finally, Citigroup reissued an “outperform” rating on shares of Privia Health Group in a research report on Friday, August 29th. Twelve investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Privia Health Group presently has a consensus rating of “Moderate Buy” and a consensus target price of $29.25.

Institutional Trading of Privia Health Group

Several institutional investors have recently added to or reduced their stakes in the business. State Street Corp boosted its position in shares of Privia Health Group by 1.5% during the second quarter. State Street Corp now owns 4,171,069 shares of the company’s stock valued at $95,935,000 after buying an additional 61,853 shares during the last quarter. Qube Research & Technologies Ltd lifted its position in Privia Health Group by 93.3% during the second quarter. Qube Research & Technologies Ltd now owns 609,278 shares of the company’s stock valued at $14,013,000 after purchasing an additional 294,101 shares during the period. Invesco Ltd. boosted its holdings in Privia Health Group by 4.6% in the second quarter. Invesco Ltd. now owns 407,899 shares of the company’s stock worth $9,382,000 after purchasing an additional 18,115 shares during the last quarter. Public Sector Pension Investment Board grew its position in Privia Health Group by 9.2% in the 2nd quarter. Public Sector Pension Investment Board now owns 357,503 shares of the company’s stock worth $8,223,000 after purchasing an additional 30,256 shares during the period. Finally, First Trust Advisors LP raised its stake in Privia Health Group by 482.7% during the 2nd quarter. First Trust Advisors LP now owns 279,005 shares of the company’s stock valued at $6,417,000 after buying an additional 231,125 shares during the last quarter. 94.48% of the stock is currently owned by hedge funds and other institutional investors.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.